首页 | 本学科首页   官方微博 | 高级检索  
     

红霉素联合雷贝拉唑治疗反流性食管炎的疗效观察
引用本文:陈樵,冯燕. 红霉素联合雷贝拉唑治疗反流性食管炎的疗效观察[J]. 西部医学, 2012, 24(10): 1943-1945
作者姓名:陈樵  冯燕
作者单位:攀枝花学院附属医院消化内科,四川攀枝花,617000
摘    要:目的观察红霉素肠溶胶囊联合雷贝拉唑治疗反流性食管炎的临床效果。方法将符合诊断标准的反流性食管炎患者100例,随机分为治疗组52例,采用红霉素肠溶胶囊联合雷贝拉唑治疗;对照组48例只用雷贝拉唑治疗。观察两组治疗前及治疗4周后的临床疗效以及内镜下病症改善的程度。结果治疗4周后治疗组有效率为94.2%;对照组有效率为79.1%,两组比较有显著性差异(P〈0.05)。内镜下反流性食管炎症状改善程度治疗组显著好于对照组(P〈0.05)。两组均未见严重不良反应。结论红霉素联合雷贝拉唑是治疗反流性食管炎安全、有效的方法。

关 键 词:反流性食管炎  红霉素肠溶胶囊  雷贝拉唑  临床疗效

Clinical observation of erythromycin combined with rabeprazole treatment of reflux esophagitis
CHEN Qiao , FENG Yan. Clinical observation of erythromycin combined with rabeprazole treatment of reflux esophagitis[J]. , 2012, 24(10): 1943-1945
Authors:CHEN Qiao    FENG Yan
Affiliation:(Department of Degestion,The Affiliated Hospital of Panzhihua College,Panzhihua 617000,Sichuan,China)
Abstract:Objective To observe clinical effect of erythromycin enteric-coated capsules and rabeprazole on treatment of reflux esophagitis.Method 100 patients with reflux esophagitis were divided into two groups,the treatment group(52 cases) treated with erythromycin intestines dissolving capsule and rabeprazole and the the control group(48 cases) with rabeprazole.The clinical curative effect of endoscopic symptoms and the degree of improvement were observed.Results After 4 weeks treatment,the total effective rate in treatment group and control group were 94.2% and 79.1%.There were no the serious adverse reactions.Conclusion Erythromycin and rabeprazole is safe and effective for reflux esophagitis.
Keywords:Flowing esophagitis  Erythromycin enteric-coated capsules combined with rabeprazole  Clinical course of observation
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号